Rossi M, Kowalski A, Björnsson E. "一种利伐沙班杂质108的合成方法" [P]. European Patent, EP 3481196 A1, 2024-03-24.
发明人冯建国,马晓峰,唐晓军. "Method for the Synthesis of Rivaroxaban Impurity 108" [P]. 中国发明专利, 专利号 CN 117617437 A, 授权公告日 2024-05-06.
发明人黄志刚,朱建伟,马晓峰. "A Process for Preparing High-Purity Rivaroxaban Impurity 108" [P]. 中国发明专利, 专利号 CN 115024800 A, 授权公告日 2021-03-22.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质108 in Pharmaceutical Formulations". J. Sep. Sci., 2015, 2199, (2), 6213-6237.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质108 as an Impurity". J. Nat. Prod., 2018, 579, (6), 2178-2189.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 108 Using HRMS and NMR". J. Chromatogr. A, 2016, 2447, (8), 3588-3602.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 利伐沙班杂质108 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2015, 773, (12), 9948-9967.